Aortic Valve Stenosis
Conditions
Brief summary
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Detailed description
A prospective single center registry including all patients treated with transcatheter aortic valve implantation (TAVI) at the Heart Center, Bad Segeberg, Germany. Patients undergo a routine clinical and echocardiographic follow-up schedule, including a long-term follow-up plan beyond 5 years to assess valve durability.
Interventions
DEVICETranscatheter Aortic Valve Implantation
Interventional replacement of the aortic valve
Sponsors
Segeberger Kliniken GmbH
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Inclusion criteria
* All patients treated with TAVI
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | Up to 10 years | Cardiovascular and not cardiovascular death |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Structural valve deterioration | Up to 10 years | Transprosthetic mean pressure gradient ≥40 mmHg and/or ≥20 mmHg rise from baseline OR severe intraprosthetic aortic regurgitation |
Countries
Germany
Contacts
Primary ContactMohamed Abdel-Wahab, MD
Backup ContactRalph Toelg
Outcome results
None listed